![DCGI gives Nod for Restricted Emergency Use to Itolizumab](https://www.gkseries.com/blog/wp-content/uploads/thumbs_dir/Itolizumab-ose9wyld5oc7d5ha84zsq425cft2ygbsp3m5hi1i1s.jpeg)
Itolizumab (rDNA origin) has now been granted Restricted Emergency Use authorisation by the Drugs Controller General of India (DCGI) based on clinical trials data. It is a monoclonal antibody which was already approved for severe chronic plaque psoriasis. Daily Current Affairs Quiz 2020 ...
READ MORE +